Elite in Ebstein's Anomaly

Nicole Nagdyman

Munich, BY, DE 
Elite in Ebstein's Anomaly
Munich, BY, DE 
OverviewLocationsClinical Research

Overview

Nicole Nagdyman practices in Munich, Germany. Ms. Nagdyman is rated as an Elite expert by MediFind in the treatment of Ebstein's Anomaly. Her top areas of expertise are Ebstein's Anomaly, Congenital Heart Disease (CHD), Congenital Cardiovascular Shunt, and Eisenmenger Syndrome.

Her clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Ebstein's Anomaly.

Gender
Female

Locations

Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

68 Total Publications

Interventional Partial Cavopulmonary Connection: Initial Clinical Experience With Acute Procedural up to Midterm Results.
Interventional Partial Cavopulmonary Connection: Initial Clinical Experience With Acute Procedural up to Midterm Results.
Journal: Journal of the American Heart Association
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nagdyman's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile